Research
Sustained clinical responses seen with neuroimmune modulation for rheumatoid arthritis
The Brief
- Twenty-four-month data show sustained clinical responses in patients receiving neuroimmune modulation therapy for rheumatoid arthritis.
- The study was presented at the annual meeting of the American College of Rheumatology, held Nov. 6 to 11 in Orlando, Florida.
Why it matters
Two years of follow-up showing sustained responses is relevant to clinicians and patients weighing long-term treatment options for rheumatoid arthritis.
Who’s affected
- rheumatologists
- patients with rheumatoid arthritis
- #rheumatoid arthritis
- #neuroimmune modulation
- #autoimmune disease
- #rheumatology
- #clinical outcomes
Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis (RA), according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
Timeline
Twenty-four-month data presented at the American College of Rheumatology annual meeting in Orlando, Florida (meeting held Nov. 6 to 11)
Medical Xpress - latest medical and health news stories
Sustained clinical responses seen with neuroimmune modulation for rheumatoid arthritis